Business Context and Reporting Period
Company: Canopy Growth Corporation (CGC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 29, 2025
Principal Executive Offices: Smiths Falls, Ontario, Canada
Reporting Period: The filing reports on events occurring on August 29, 2025, specifically the establishment of a new equity distribution program.
Key Financial Metrics
This filing is a current report regarding a corporate action and does not contain audited financial statements, revenue, profit, cash flow, or margin data for a specific reporting period.
- Proposed Capital Raise: Up to $200,000,000 aggregate offering price of Common Shares.
- Canadian Cap: Maximum of $50,000,000 in gross sales proceeds from the Concurrent Canadian Offering.
- U.S. Offering Limit: The remainder of the $200,000,000 total, subject to the Canadian Cap.
- Debt and Liquidity: The filing text does not provide a clear value for current debt levels or liquidity positions.
Material Changes
The primary material change is the execution of a new Equity Distribution Agreement, replacing the previous agreement dated February 28, 2025.
- New Agreement: Entered into with BMO Capital Markets Corp. (U.S. Agent) and BMO Nesbitt Burns Inc. (Canadian Agent).
- Termination of Prior Agreement: The previous equity distribution agreement terminated upon the execution of this new agreement.
- Sales Method: Shares will be sold via "at-the-market" offerings on the Nasdaq Global Select Market (U.S.) and the Toronto Stock Exchange (Canada).
Guidance, Outlook, and Risks
Management Commentary: The Company retains full discretion over the timing and volume of share sales. Actual sales depend on market conditions, trading price, capital needs, and funding source determinations.
Outlook: The Company has no obligation to sell any shares and may suspend offers or terminate the agreement at any time.
Risks and Contingencies:
- Dilution Risk: Issuance of up to $200 million in new shares may dilute existing shareholders.
- Market Conditions: Sales are contingent on favorable market conditions and trading prices.
- Legal Limitations: Representations and warranties in the agreement are for the benefit of the parties only and should not be relied upon by investors as characterizations of actual facts.
Investor Verification Checklist
- Verify the current trading price of CGC common shares to assess potential dilution impact from the $200 million program.
- Review the full text of the Equity Distribution Agreement (Exhibit 1.1) for specific termination clauses and agent compensation terms.
- Confirm the status of the Company's shelf registration statement (File No. 333-279949) and its amendments.
- Monitor future filings for actual sales volumes executed under this new program.
- Check for any concurrent press releases (Exhibit 99.1) for additional strategic context not detailed in the 8-K.